1. Wollina U. Pompholyx: A Review of Clinical Features, Differential Diagnosis, and Management. 2010;11(5):305–14.
2. Pearce VJ, Mortimer PS. Hand dermatitis and lymphoedema. Br J Dermatol. 2009;161(1):177–80.
3. Brazzelli V, Grassi S, Savasta S, Ruffinazzi G, Carugno A, Barbaccia V, et al. Pompholyx of the hands after intravenous immunoglobulin therapy for clinically isolated syndrome: A paediatric case. Int J Immunopathol Pharmacol. 2014;27(1):127–30.
4. Kurata M, Horie C, Kano Y, Shiohara T. Pompholyx as a clinical manifestation suggesting increased serum IgG levels in a patient with drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms. Br J Dermatol. 2016;174(3):681–3.
5. Kim DY, Kim JY, Kim TG, Kwon JE, Sohn H, Park J, et al. A comparison of inflammatory mediator expression between palmoplantar pustulosis and pompholyx. J Eur Acad Dermatology Venereol. 2013;27(12):1559–65.
6. Tchernev G, Zanardelli M, Voicu C, Bakardzhiev I, Lotti T, Lotti J, et al. Impetiginized Dyshidrotic Eczema. Open Access Maced J Med Sci [Internet]. 2017;5(4):539.
7. Amini S. Dyshidrotic Eczema. Medscape, 2018. https://emedicine.medscape.com/article/1122527-treatment
8. Wollina U. Pompholyx: what’s new? Expert Opin Investig Drugs [Internet]. 2008;17(6):897–904.
9. Francis NA, Ridd MJ, Thomas-Jones E, Shepherd V, Butler CC, Hood K, et al. A randomised placebo-controlled trial of oral and topical antibiotics for children with clinically infected eczema in the community: The ChildRen with eczema, antibiotic management (CREAM) study. Health Technol Assess (Rockv). 2016;20(19).
10. Warshaw E. Therapeutic options for chronic hand dermatitis. Dermatol Ther. 2004;17:240–50.
Facebook 
Masuk dengan Email
